Outcomes4Me is optimistic that a newly inked deal with Labcorp and partnerships with pharmaceutical companies will help it improve cancer patients’ access to biomarker testing and precision treatment.
Outcomes4Me is optimistic that a newly inked deal with Labcorp and partnerships with pharmaceutical companies will help it improve cancer patients’ access to biomarker testing and precision treatment.